Report cover image

Direct-to-Consumer Genetic Testing Market Report and Forecast 2025-2034

Publisher Expert Market Research
Published Jul 29, 2025
Length 350 Pages
SKU # EMAR20319982

Description

The global direct-to-consumer genetic testing market size was valued at USD 1.90 Billion in 2024, driven by the rising number of global research and development activities. The market size is anticipated to grow at a CAGR of 20.70% during the forecast period of 2025-2034 to achieve a value of USD 12.47 Billion by 2034.

Direct-to-Consumer Genetic Testing: Introduction

Direct-to-consumer genetic tests allow consumers to access genetic testing without the direct involvement of healthcare providers. Direct-to-consumer genetic tests (DTC-GT) are genetic tests that are distributed directly to consumers to provide genetic information such as ancestry, health traits and health risks) with help of a saliva sample. These tests could be accurate and effective but still it is recommended to use health care professional’s advice to perform these tests.

Global Direct-to-Consumer Genetic Testing Market Analysis

The continuous technological innovations generating widespread interest from academics, clinicians, and consumers alike for consumer genetic testing has been driving the growth of the market. Polygenic score is the latest advancement in genomics which can potentially expand understandings of the scope and role of DTC genetic testing, which is expected to further propel the market growth. With Direct-to-consumer (DTC) genetic testing equipment there is no requirement for healthcare professionals to be around which is expected to reduce expenses and increase the availability to potential patients, further contributing to the direct-to-consumer genetic testing market growth.

The increasing health awareness among people is expanding the market significantly and this awareness has majorly been experienced in developed countries such as United States, Canada, and the United Kingdom. The rising prevalence of chronic diseases, including cancer, Alzheimer's disease, and Parkinson's disease are also driving the market growth. The increasing research and development on innovative genetic testing approaches are further expected to intensify the market growth.

Global Direct-to-Consumer Genetic Testing Market Segmentations

Direct-to-Consumer Genetic Testing Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Test Type
  • Carrier Testing
  • Predictive Testing
  • Ancestry and Relationship Testing
  • Nutrigenomics Testing
  • Others
Market Breakup by Technology
  • Targeted Analysis
  • Single Nucleotide Polymorphism (SNP) Chips
  • Whole Genome Sequencing (WGS)
Market Breakup by Sales Channel
  • Institutional Sales
  
  • Hospitals

    •   
  • Speciality Clinics

    •   
  • Diagnostic Laboratories

    •   
  • Others
    • Retail Sales
      
  • Retail Pharmacies

    •   
  • Online sales

    • Market Breakup by End User
    • Laboratories
    • Blood Banks
    • Nursing Homes
    • Hospitals
    • Imaging Centres
    • Home Care
    • Cosmetics
    • Others
    Market Breakup by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Global Direct-to-Consumer Genetic Testing Market Overview

    The increasing popularity of genetic testing among people and healthcare professionals are among major factors driving the market growth. The continuous advancements in technology are the reason that genealogy testing has become more accessible and affordable and this has directly increased its demand in the market. The pharmacogenetics has been witnessing significant traction recently and it is expected to expand the DTC testing space which will further increase the market growth. The increasing demand for precision and personalized medicine in clinics and increasing awareness about precision medicine is also expected to intensify the adoption of DTC genetic testing and increase the market demand. The high efficacy and accuracy of DTC genetic testing is also set to drive the market growth.

    North America is leading the regional market and is expected to drive the market growth. The increased public awareness about direct-to-consumer genetic tests among regional population is a major factor responsible for market growth.

    Global Direct-to-Consumer Genetic Testing Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • Counsyl
    • Gene by Gene
    • Easy DNA
    • Karmagenes SA
    • Living DNA Ltd.
    • Helix OpCo LLC
    • Full Genome Corporation Inc.
    • Genesis Healthcare Co.
    • The SkinDNA Company Pty Ltd
    • DNA Genotek Inc.
    • DNA Diagnostic Center
    • Dante Lab
    • Ambry Genetics
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Global Direct-to-Consumer Genetic Testing Market Overview
    3.1 Global Direct-to-Consumer Genetic Testing Market Historical Value (2018-2024)
    3.2 Global Direct-to-Consumer Genetic Testing Market Forecast Value (2025-2034)
    4 Global Direct-to-Consumer Genetic Testing Market Landscape
    4.1 Global Direct-to-Consumer Genetic Testing Developers Landscape
    4.1.1 Analysis by Year of Establishment
    4.1.2 Analysis by Company Size
    4.1.3 Analysis by Region
    4.2 Global Direct-to-Consumer Genetic Testing Product Landscape
    4.2.1 Analysis by Test Type
    4.2.2 Analysis by Technology
    5 Global Direct-to-Consumer Genetic Testing Market Dynamics
    5.1 Market Drivers and Constraints
    5.2 SWOT Analysis
    5.3 Porter’s Five Forces Model
    5.4 Key Demand Indicators
    5.5 Key Price Indicators
    5.6 Industry Events, Initiatives, and Trends
    5.7 Value Chain Analysis
    6 Global Direct-to-Consumer Genetic Testing Market Segmentation
    6.1 Global Direct-to-Consumer Genetic Testing Market by Test Type
    6.1.1 Market Overview
    6.1.2 Carrier Testing
    6.1.3 Predictive Testing
    6.1.4 Ancestry and Relationship Testing
    6.1.5 Nutrigenomics Testing
    6.1.6 Others
    6.2 Global Direct-to-Consumer Genetic Testing Market by Technology
    6.2.1 Market Overview
    6.2.2 Targeted Analysis
    6.2.3 Single Nucleotide Polymorphism (SNP) Chips
    6.2.4 Whole Genome Sequencing (WGS)
    6.3 Global Direct-to-Consumer Genetic Testing Market by Sales Channel
    6.3.1 Market Overview
    6.3.2 Institutional Sales
    6.3.2.1 Hospitals
    6.3.2.2 Speciality Clinics
    6.3.2.3 Diagnostic Laboratories
    6.3.2.4 Others
    6.3.3 Retail Sales
    6.3.3.1 Retail Pharmacies
    6.3.3.2 Online sales
    6.4 Global Direct-to-Consumer Genetic Testing Market by End User
    6.4.1 Laboratories
    6.4.2 Blood Banks
    6.4.3 Nursing Homes
    6.4.4 Hospitals
    6.4.5 Imaging Centres
    6.4.6 Home Care
    6.4.7 Cosmetics
    6.4.8 Others
    6.5 Global Direct-to-Consumer Genetic Testing Market by Region
    6.5.1 Market Overview
    6.5.2 North America
    6.5.3 Europe
    6.5.4 Asia Pacific
    6.5.5 Latin America
    6.5.6 Middle East and Africa
    7 North America Direct-to-Consumer Genetic Testing Market
    7.1 Market Share by Country
    7.2 United States of America
    7.3 Canada
    8 Europe Direct-to-Consumer Genetic Testing Market
    8.1 Market Share by Country
    8.2 United Kingdom
    8.3 Germany
    8.4 France
    8.5 Italy
    8.6 Others
    9 Asia Pacific Direct-to-Consumer Genetic Testing Market
    9.1 Market Share by Country
    9.2 China
    9.3 Japan
    9.4 India
    9.5 ASEAN
    9.6 Australia
    9.7 Others
    10 Latin America Direct-to-Consumer Genetic Testing Market
    10.1 Market Share by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Mexico
    10.5 Others
    11 Middle East and Africa Direct-to-Consumer Genetic Testing Market
    11.1 Market Share by Country
    11.2 Saudi Arabia
    11.3 United Arab Emirates
    11.4 Nigeria
    11.5 South Africa
    11.6 Others
    12 Patent Analysis
    12.1 Analysis by Type of Patent
    12.2 Analysis by Publication year
    12.3 Analysis by Issuing Authority
    12.4 Analysis by Patent Age
    12.5 Analysis by CPC Analysis
    12.6 Analysis by Patent Valuation
    12.7 Analysis by Key Players
    13 Grants Analysis
    13.1 Analysis by year
    13.2 Analysis by Amount Awarded
    13.3 Analysis by Issuing Authority
    13.4 Analysis by Grant Application
    13.5 Analysis by Funding Institute
    13.6 Analysis by NIH Departments
    13.7 Analysis by Recipient Organization
    14 Funding Analysis
    14.1 Analysis by Funding Instances
    14.2 Analysis by Type of Funding
    14.3 Analysis by Funding Amount
    14.4 Analysis by Leading Players
    14.5 Analysis by Leading Investors
    14.6 Analysis by Geography
    15 Partnership and Collaborations Analysis
    15.1 Analysis by Partnership Instances
    15.2 Analysis by Type of Partnership
    15.3 Analysis by Leading Players
    15.4 Analysis by Geography
    16 Regulatory Framework
    16.1 Regulatory Overview
    16.1.1 US FDA
    16.1.2 EU EMA
    16.1.3 INDIA CDSCO
    16.1.4 JAPAN PMDA
    16.1.5 Others
    17 Supplier Landscape
    17.1 Counsyl
    17.1.1 Financial Analysis
    17.1.2 Product Portfolio
    17.1.3 Demographic Reach and Achievements
    17.1.4 Mergers and Acquisitions
    17.1.5 Certifications
    17.2 Gene by Gene
    17.2.1 Financial Analysis
    17.2.2 Product Portfolio
    17.2.3 Demographic Reach and Achievements
    17.2.4 Mergers and Acquisitions
    17.2.5 Certifications
    17.3 Easy DNA
    17.3.1 Financial Analysis
    17.3.2 Product Portfolio
    17.3.3 Demographic Reach and Achievements
    17.3.4 Mergers and Acquisitions
    17.3.5 Certifications
    17.4 Karmagenes SA
    17.4.1 Financial Analysis
    17.4.2 Financial Portfolio
    17.4.3 Demographic Reach and Achievements
    17.4.4 Mergers and Acquisitions
    17.4.5 Certifications
    17.5 Living DNA Ltd.
    17.5.1 Financial Analysis
    17.5.2 Product Portfolio
    17.5.3 Demographic Reach and Achievements
    17.5.4 Mergers and Acquisitions
    17.5.5 Certifications
    17.6 Helix OpCo LLC
    17.6.1 Financial Analysis
    17.6.2 Product Portfolio
    17.6.3 Demographic Reach and Achievements
    17.6.4 Mergers and Acquisitions
    17.6.5 Certifications
    17.7 Full Genome Corporation Inc.
    17.7.1 Financial Analysis
    17.7.2 Product Portfolio
    17.7.3 Demographic Reach and Achievements
    17.7.4 Mergers and Acquisitions
    17.7.5 Certifications
    17.8 Genesis Healthcare Co.
    17.8.1 Financial Analysis
    17.8.2 Product Portfolio
    17.8.3 Demographic Reach and Achievements
    17.8.4 Mergers and Acquisitions
    17.8.5 Certifications
    17.9 The SkinDNA Company Pty Ltd
    17.9.1 Financial Analysis
    17.9.2 Product Portfolio
    17.9.3 Demographic Reach and Achievements
    17.9.4 Mergers and Acquisitions
    17.9.5 Certifications
    17.10 DNA Genotek Inc.
    17.10.1 Financial Analysis
    17.10.2 Product Portfolio
    17.10.3 Demographic Reach and Achievements
    17.10.4 Mergers and Acquisitions
    17.10.5 Certifications
    17.11 DNA Diagnostic Center
    17.11.1 Financial Analysis
    17.11.2 Product Portfolio
    17.11.3 Demographic Reach and Achievements
    17.11.4 Mergers and Acquisitions
    17.11.5 Certifications
    17.12 Dante Lab
    17.12.1 Financial Analysis
    17.12.2 Product Portfolio
    17.12.3 Demographic Reach and Achievements
    17.12.4 Mergers and Acquisitions
    17.12.5 Certifications
    17.13 Ambry Genetics
    17.13.1 Financial Analysis
    17.13.2 Product Portfolio
    17.13.3 Demographic Reach and Achievements
    17.13.4 Mergers and Acquisitions
    17.13.5 Certifications
    18 Global Direct-to-Consumer Genetic Testing Market - Distribution Model (Additional Insight)
    18.1 Overview
    18.2 Potential Distributors
    18.3 Key Parameters for Distribution Partner Assessment
    19 Key Opinion Leaders (KOL) Insights (Additional Insight)
    20 Company Competitiveness Analysis (Additional Insight)
    20.1 Very Small Companies
    20.2 Small Companies
    20.3 Mid-Sized Companies
    20.4 Large Companies
    20.5 Very Large Companies
    21 Payment Methods (Additional Insight)
    21.1 Government Funded
    21.2 Private Insurance
    21.3 Out-of-Pocket

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us